| Warren Edward Gall, MD | |
|
1000 Langworthy St, Dubuque, IA 52001-7313 | |
| (563) 584-3445 | |
| (563) 584-3497 |
| Full Name | Warren Edward Gall |
|---|---|
| Gender | Male |
| Speciality | Thoracic Surgery (cardiothoracic Vascular Surgery) |
| Location | 1000 Langworthy St, Dubuque, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265482277 | NPI | - | NPPES |
| 0094102 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | 21386 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Warren Edward Gall, MD 1500 Associates Dr, Dubuque, IA 52002-2201 Ph: (563) 584-4100 | Warren Edward Gall, MD 1000 Langworthy St, Dubuque, IA 52001-7313 Ph: (563) 584-3445 |
News Archive
Centhaquine, a new medication to treat patients who have severe blood or fluid loss, significantly improved outcomes and reduced death rate when added to standard of care, compared to standard care alone, according to preliminary research to be presented at the American Heart Association's Resuscitation Science Symposium 2020.
Researchers have found that a drug can heal heart muscles in mice. Earlier it was considered that this damage to the heart is permanent but this new findings refutes earlier beliefs.
The bacterium that causes tuberculosis has a unique molecule on its outer cell surface that blocks a key part of the body's defense. New research suggests this represents a novel mechanism in the microbe's evolving efforts to remain hidden from the human immune system.
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, is expanding its Tuberculosis Research Units program in an effort to drive innovation in tuberculosis (TB) research. NIAID is awarding up to $15.2 million in fiscal year 2015 and as much as $105.3 million over seven years to fund four institutions that will act as a collaborative TBRU network.
Critical Outcome Technologies Inc. announced more positive results today from animal experiments carried out at a prominent Canadian cancer research facility. This new series of experiments adds to the impressive data package for COTI-2, demonstrating efficacy both as a single agent and in combination with current first line therapies, as well as low toxicity in several different animal models of human cancers.
› Verified 4 days ago
Dr. Lance Anthony Bezzina, D.O. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1000 Langworthy St, Dubuque, IA 52001 Phone: 563-584-3445 Fax: 563-584-3446 | |
Dr. Sinan Ali Simsir, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1000 Langworthy St, Dubuque, IA 52001 Phone: 563-584-3445 Fax: 563-584-3446 |